Chicago Partners Investment Group LLC reduced its stake in UnitedHealth Group Inc (NYSE:UNH) by 49.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 561 shares of the healthcare conglomerate’s stock after selling 538 shares during the period. Chicago Partners Investment Group LLC’s holdings in UnitedHealth Group were worth $110,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of UNH. Blue Chip Partners Inc. bought a new position in shares of UnitedHealth Group during the second quarter valued at approximately $110,000. Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its stake in shares of UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares in the last quarter. BDO Wealth Advisors LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at approximately $121,000. Finally, Acrospire Investment Management LLC boosted its stake in shares of UnitedHealth Group by 130.7% during the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 400 shares in the last quarter. Institutional investors and hedge funds own 86.00% of the company’s stock.

A number of equities analysts have recently issued reports on the stock. Deutsche Bank increased their price objective on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Wells Fargo & Co reiterated an “outperform” rating and set a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, December 1st. Citigroup increased their price objective on shares of UnitedHealth Group from $213.00 to $235.00 and gave the company a “buy” rating in a research note on Wednesday, October 18th. Finally, BMO Capital Markets assumed coverage on shares of UnitedHealth Group in a research report on Monday, October 16th. They set an “outperform” rating and a $250.00 target price for the company. Two analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $243.22.

In other UnitedHealth Group news, Director Michele J. Hooper sold 5,000 shares of the firm’s stock in a transaction on Monday, December 4th. The shares were sold at an average price of $222.20, for a total value of $1,111,000.00. Following the completion of the transaction, the director now owns 36,989 shares of the company’s stock, valued at $8,218,955.80. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Michele J. Hooper sold 10,000 shares of the firm’s stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $237.76, for a total transaction of $2,377,600.00. Following the completion of the transaction, the director now directly owns 37,284 shares of the company’s stock, valued at approximately $8,864,643.84. The disclosure for this sale can be found here. In the last ninety days, insiders sold 53,396 shares of company stock valued at $12,262,067. Corporate insiders own 0.89% of the company’s stock.

UnitedHealth Group Inc (UNH) opened at $225.69 on Tuesday. The stock has a market cap of $218,710.00, a price-to-earnings ratio of 21.07, a price-to-earnings-growth ratio of 1.29 and a beta of 0.70. UnitedHealth Group Inc has a fifty-two week low of $156.49 and a fifty-two week high of $250.79. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the company posted $2.11 earnings per share. sell-side analysts expect that UnitedHealth Group Inc will post 12.51 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece was published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.watchlistnews.com/unitedhealth-group-inc-unh-shares-sold-by-chicago-partners-investment-group-llc/1862790.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.